Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04239508

Swiss Neonatal Network & Follow-up Group

The chief aim of the Swiss Neonatal Network & Follow-Up Group (SwissNeoNet) is to maintain and / or improve the quality and safety of medical care for high-risk newborn infants and their families in Switzerland through a coordinated program of research, education and collaborative audit. In support of its aim, SwissNeoNet hosts the official medical quality register for the Swiss level III and level IIB units. Participation for these units is mandatory according to the intercantonal declaration for Highly Specialized Medicine (HSM) of September 22, 2011 and the Society's Standards for Levels of Neonatal Care in Switzerland.

Recruiting

Interested in participating?

Request Info

Key information

Age range

0 day–28 day

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Neonatology

Zurich, 8091, Switzerland

Location status: Recruiting

Location contact

Mark Adams, PhD

CONTACT

[email protected]

+41432533034

About this study

Inaugurated in 1995, SwissNeoNet now routinely collects data from 9 level III, 10 level IIB and 14 neuro-/developmental pediatric units encompassing information about the care and outcomes of high-risk newborn infants. Data collection is monitored for population coverage, dataset completeness, plausibility and reliability. Data quality is audited within a three year cycle.

Quality improvement

SwissNeoNet releases an annual quality report for participating centers encompassing up to 20 process- and outcome quality indicators. It annually collects data on unit infrastructure evaluated by the Committee for the Accreditation of Neonatology Units (CANU). To discuss quality issues and educational purposes, it hosts bi-annual meetings/symposia for the NEO Directors Group and the Follow-up Group, respectively. The SwissNeoNet member platform offers tools for unit-to-unit quality improvement collaboration (mailing lists, event-organizer, forum, file-sharing and survey builder).

Research

SwissNeoNet coordinates cross-sectional and longitudinal cohort studies that are performed by local researchers using SwissNeoNet's prospectively collected data. These studies focus on mortality, morbidity and/or long-term outcome issues and the analysis of risk factors for development. The network disseminates its research in scientific articles in peer reviewed medical journals.

Support

SwissNeoNet supports the units logistically to ensure that each patient receives primary care (NICU bed availability) and follow-up assessments at 9 to 12 months corrected, 18 to 24 months corrected, and at 5.5 to 6 years of age (FU missing lists) to ensure early diagnosis and intervention. With regards to its Follow-up program, the SwissNeoNet also supports training of new staff and coordinates the launch of new testing instruments between centers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

of "Minimal Neonatal Dataset" (MNDS):

All Swiss live-born infants below 32 weeks gestational age or 1501g birth weight

Inclusion criteria

of "Below 34 data collection", (B34):

All Swiss live-born infants between 32 0/1 and 33 6/7 weeks gestational age that are above 1500g birth weight

Inclusion criteria

of "Swiss Asphyxia and Cooling Registry", (ASP):

Infants between 35 0/7 and 42 6/7 weeks' gestational age with moderate or severe encephalopathy due to perinatal asphyxia

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: 0 to 6 years

    Mortality in delivery room, during primary hospitalization or within first 6 years of life

  2. Major morbidities of newborns

    Time frame: 0 to 6 years

    Period prevalences (i.e. incident proportions per year or period of years) of intraventricular hemorrhages, necrotizing enterocolitis, sepsis, retinopathy of prematurity, bronchopulmonary displasia, neurodevelopmental impairment at 2 or 6 years, and other

Study contacts

Contact information is provided by the study sponsor or research team.

Dirk Bassler, MD, MSc

CONTACT

[email protected]

Mark Adams, PhD

CONTACT

[email protected]

+41432533034

Sponsors and collaborators

Lead sponsor

Swiss Neonatal Network

Network

Collaborators

  • Cantonal Hospital of St. Gallen
  • Department of Child Development, Children's Hospital St. Gallen, Switzerland
  • Department of Neonatology, Cantonal Hospital Winterthur, Switzerland
  • Department of Neonatology, Children's Clinic, Cantonal Hospital Aarau, Switzerland
  • Department of Neonatology, Children's Hospital Chur, Switzerland
  • Department of Neonatology, University Hospital Berne, Switzerland
  • Department of Neuropaediatrics, Children's Clinic, Cantonal Hospital Aarau, Switzerland
  • Department of Neuropaediatrics, Children's Hospital Chur, Switzerland
  • Department of Neuropaediatrics, University Hospital Berne, Switzerland
  • Department of Neuropediatrics, Cantonal Hospital Fribourg, Switzerland
  • Department of Pediatrics, Cantonal Hospital Muensterlingen, Switzerland
  • Department of Pediatrics, Cantonal Hospital Neuchatel, Switzerland
  • Department of Pediatrics, San Giovanni Hospital Bellinzona, Switzerland
  • Development and Pediatric Neurorehabilitation Center, Biel, Switzerland
  • Neonatal and Paediatric Intensive Care Unit, Children's Hospital of Lucerne, Switzerland
  • Social Pediatrics Center, Cantonal Hospital Winterthur, Switzerland
  • University Children's Hospital Basel
  • University Children's Hospital, Zurich
  • University Hospital, Geneva
  • University Hospital, Zürich
  • University of Lausanne Hospitals

Registry information

Acronym: SwissNeoNet

Important dates

Study start
2000
Primary completion
2050
Study completion
2050
First posted
Jan 27, 2020
Registry last updated
Jun 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.